Late-StageResearch compound

Cerebrolysin

Porcine brain peptide hydrolysate, EU Rx, stroke + dementia.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

WHAT IS CEREBROLYSIN?

Detailed overview

Cerebrolysin (EVER Pharma, Austria) is a biological medicine hydrolyzed from porcine brain cortex into peptide and free amino acid fractions (the FPF1070 enzymatic process). 25% peptides (<10 kDa), 75% free amino acids. Clinical evidence: **CASTA trial (Heiss 2012, PMID 22744651)** – acute ischemic stroke, intent-to-treat NIH SS improvement; **CARS-1 trial (Muresanu 2016, PMID 26669311)** – stroke rehabilitation, statistically significant functional recovery. Mechanism: NGF, BDNF, GDNF, CNTF-like peptide activity → neurogenesis in the subventricular zone, anti-excitotoxic + anti-apoptotic effects. Administration: 10-30 ml i.v. infusion over 10-20 days (acute stroke), repeatable every 4-6 weeks. Prescription-only in Hungary and several EU member states (AT, PL, RU, CN). Not FDA-approved in the USA (cannot be classified under standard biological-drug categories).

Mechanism

Neurotrophic + neuroprotective peptides

Route

i.v. / i.m. injection

Legal status

EU Rx (HU, AT)

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Dizziness, vertigo and headache
  • Heat sensation, sweating, palpitations with too-rapid infusion
  • Agitation, restlessness, occasionally insomnia or sleep disturbance
  • Nausea, vomiting, loss of appetite, diarrhoea
  • Local injection-site reaction, flushing
  • Rare hypersensitivity/allergic reaction (rash, itching)

Contraindications · 6

  • Known hypersensitivity to the peptide preparation
  • Status epilepticus and grand mal seizures (may lower seizure threshold)
  • Severe renal impairment
  • Pregnancy and breastfeeding (insufficient safety data)
  • Concurrent antidepressants/MAO inhibitors: dose adjustment advised due to additive effects
  • Slow i.v./i.m. administration only; not to be mixed with balanced amino-acid infusions

Related Nootropics

Same therapeutic category

Telegram

Have a question about Cerebrolysin?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.